MedTrace Logo

Genetic and Molecular Abnormalities in Congenital Cystic Adenomatoid Malformations

NCT01732185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-09-08

No results posted yet for this study

Summary

The aim of this study is to identify genetic abnormalities and molecular pathways associated with the occurrence of CCAM.

Conditions

  • Congenital Cystic Adenomatoid Malformation (CCAM)

Interventions

GENETIC

Patient

Blood and histological samples will be done at day of the inclusion.

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Christophe Delacourt, MD, PhD · Necker-Enfants Malades Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-11
Primary Completion
2015-10-11
Completion
2015-10-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01732185 on ClinicalTrials.gov